{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-455762","form_type":"8-K","ticker":"RLYB","cik":"0001739410","company_name":"Rallybio Corp","filed_at":"2026-11-10T22:20:38+00:00","discovered_at":"2026-11-10T22:22:00.306745+00:00","generated_at":"2026-11-10T22:22:10.002201+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Rallybio sets 1-for-2 reverse stock split effective Nov. 20 ahead of Avenzo merger","bullets":["Board approved a one-for-two reverse split on Nov. 8, 2026; effective 12:01 a.m. ET on Nov. 20, 2026, before the anticipated merger close.","Issued and outstanding shares will fall from about 5.6 million to about 2.8 million; authorized shares and $0.0001 par value remain unchanged.","After Nasdaq approvals and merger close, Rallybio plans to rename itself Avenzo Therapeutics and trade under ticker \"AVZO\" with CUSIP 053928 107.","Merger agreement dated May 31, 2026 with Avenzo Therapeutics and Farmington Merger Sub; stockholders approved a split range of 1-for-2 to 1-for-9 on Nov. 4.","No fractional shares will be issued; holders will receive cash equal to fair market value based on the closing price on the split's effective date, with Computershare as exchange agent."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-455762","json":"https://secwatch.observer/filing/0001193125-26-455762.json","markdown":"https://secwatch.observer/filing/0001193125-26-455762.md","text":"https://secwatch.observer/filing/0001193125-26-455762.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739410/000119312526455762/0001193125-26-455762-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739410/000119312526455762/d162317d8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-11-10T22:22:10.002201+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}